Mankind Pharma Unclassified
FDA Approved Drugs

Mankind Pharma Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 11
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
143
View
Unclassified
11
View
Discontinued
15
View
RX
117
View
Company Overview

Company

Mankind Pharma Unclassified

Country

India

Website

Visit Website

Email

contact@mankindpharma.com

Social Profiles

Company Snapshot

Mankind Pharma Unclassified

208, Okhla Industrial Estate, Phase III, New Delhi - 110020

India

www.mankindpharma.com/ contact@mankindpharma.com View on Map
FDA Approved Drug Records ( 11 records )
-
Unclassified Application: 218089

Drug Name

REVEFENACIN

Product Number

1

Dosage Form

-

Strength

175MCG/3ML

Approval Date

-

218089 / 1

Active Ingredient

REVEFENACIN

Application Number

218089

Product Number

1

Dosage Form

-

Strength

175MCG/3ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216919

Drug Name

SITAGLIPTIN

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

216919 / 1

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

216919

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216919

Drug Name

SITAGLIPTIN

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

216919 / 2

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

216919

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216919

Drug Name

SITAGLIPTIN

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

-

216919 / 3

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

216919

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218971

Drug Name

SITAGLIPTIN AND METFORMIN HCL

Product Number

1

Dosage Form

-

Strength

1000MG ER TABLET

Approval Date

-

218971 / 1

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

218971

Product Number

1

Dosage Form

-

Strength

1000MG ER TABLET

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218971

Drug Name

SITAGLIPTIN AND METFORMIN HCL

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE TABLET

Approval Date

-

218971 / 2

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

218971

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE TABLET

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218971

Drug Name

SITAGLIPTIN AND METFORMIN HCL

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

218971 / 3

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

218971

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218971

Drug Name

SITAGLIPTIN AND METFORMIN HCL

Product Number

4

Dosage Form

-

Strength

50MG

Approval Date

-

218971 / 4

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

218971

Product Number

4

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218971

Drug Name

SITAGLIPTIN AND METFORMIN HCL

Product Number

5

Dosage Form

-

Strength

1000MG

Approval Date

-

218971 / 5

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

218971

Product Number

5

Dosage Form

-

Strength

1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218405

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

218405 / 2

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

218405

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218405

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

218405 / 3

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

218405

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    14 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    143 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
11 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

REVEFENACIN

Application Number

218089

Product Number

1

Active Ingredient

REVEFENACIN

Dosage Form

-

Strength

175MCG/3ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit